Decheng Capital
About Us
Team
Portfolio
News
Contact
A Global Life Sciences Investment Firm
Established in 2012
$2.1 Billion of Capital
Building Legendary Companies
In The News
December 12, 2018
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing
October 30, 2018
Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer
October 3, 2019
VelosBio raises $58M in Series A round for antibody-drug conjugate development
August 8, 2018
Apexigen Raises $73 Million In Series B And Series C Financings
August 3, 2018
IMPACT Therapeutics Raises $30 Million In Series C Financing
July 30, 2018
Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology
July 17, 2018
Polares raises $25M to bring its 'hemi-replacement' mitral valve to the clinic
June 14, 2018
Mindstrong Health Announces $15M Series B Round Financing and Business Update
May 10, 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
March 4, 2018
LevitasBio Secures $8 Million in Series A Funding
January 25, 2018
ARMO BioSciences Announces Pricing of Initial Public Offering
Archive
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
